Galegenimab
Galegenimab (FHTR 2163; RG 6147; RO 7171009), an anti-High-temperature requirement A1 (HTRA1) antibody fragment. Galegenimab can be used for age-related macular degeneration (AMD) research[1].
Product Specifications
CAS Number
[2403683-24-7]
Product Name Alternative
FHTR 2163; RG 6147; RO 7171009
UNSPSC
12352203
Target
Ser/Thr Protease
Type
Inhibitory Antibodies
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/galegenimab.html
Purity
99.91
Solubility
10 mM in DMSO
Smiles
[Galegenimab]
Molecular Weight
(47.71 kDa)
References & Citations
[1]Jonathan B Lin, et al. Neuroprotection for Age-Related Macular Degeneration. Ophthalmol Sci. 2022 Jul 5;2 (4) :100192.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
302369-FITC 100 µL
CSNK2A3 (Casein Kinase II Subunit alpha 3, CK II alpha 3, Casein Kinase II alpha 1 Polypeptide Pseudogene, CSNK2A3, CSNK2A1P) (FITC) discontinued
Ask
View Details MBS1285648-01 0.02 mg (E-Coli)
Recombinant Schizosaccharomyces pombe Chromatin-remodeling complex subunit ies6 (ies6)
Ask
View Details MBS1285648-02 0.1 mg (E-Coli)
Recombinant Schizosaccharomyces pombe Chromatin-remodeling complex subunit ies6 (ies6)
Ask
View Details MBS1285648-03 0.02 mg (Yeast)
Recombinant Schizosaccharomyces pombe Chromatin-remodeling complex subunit ies6 (ies6)
Ask
View Details